Research
Leerink Partners Initiates Obsidian Therapeutics at Outperform With $32 Price Target
$OBX
$OBX
3 stories mentioning OBXUpdated 16h ago
Every FINWIRES story that references OBX, newest first.
What are analysts saying about OBX?
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
